FDA Inspection
Taiho Pharmaceutical Co., Ltd.Taiho Pharmaceutical Co., Ltd. – FDA Inspection, Jan 26, 2024
Record Details
This FDA Inspection record concerns Taiho Pharmaceutical Co., Ltd., with an inspection on January 26, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 1b51b09e-6eb1-4f0e-af84-0bb95d52e471
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1227779
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Taiho Pharmaceutical Co., Ltd.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| May 22, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Taiho Pharmaceutical Co., Ltd.
- FDA Inspection 930223 - 2015-05-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.